Abstract
Oxadiazole moiety, which is one of the heterocyclic aromatic groups of the azole family; with the molecular formula C2H2N2O, exists in four isomeric form; out of which, 1,2,4-oxadiazole; 1,2,5-oxadiazole and 1,3,4-oxadiazole are common isomers. The stable isomeric forms of oxadiazoles are observed in a variety of pharmaceutical important potent drugs including raltegravir, butalamine, fasiplon, oxolamine and pleconaril. An attempt has been made to emphasize the chemistry and pharmacology associated with oxadiazole and its derivatives. A number of oxadiazole derivatives are very popular and common in use as potential therapeutic agents. However, a number of researchers are working and have worked to find out more synthetic analogues for anticancer and antifungal, anti-HIV agents using biological and in-silico models.
Keywords: Oxadiazole, anti-bacterial activity, analgesic activity, anti-inflammatory activity, anti-convulsant activity, anticancer activity, anti-tubercular activity.
Graphical Abstract
[http://dx.doi.org/10.3390/molecules23123361]
[http://dx.doi.org/10.1021/jm2013248] [PMID: 22185670]
[http://dx.doi.org/10.1021/jm990229t] [PMID: 10514279]
[http://dx.doi.org/10.1128/AAC.43.9.2109] [PMID: 10471549]
[http://dx.doi.org/10.1158/1535-7163.MCT-12-0975] [PMID: 23723122]
[http://dx.doi.org/10.1186/1472-6904-11-3] [PMID: 21414193]
[http://dx.doi.org/10.1073/pnas.1615548113] [PMID: 27791186]
[http://dx.doi.org/10.2174/0929867053363540] [PMID: 15638729]
[http://dx.doi.org/10.3390/molecules15010502] [PMID: 20110905]
[http://dx.doi.org/10.3987/COM-99-8722]
[http://dx.doi.org/10.1016/j.ejmech.2017.12.067] [PMID: 29310025]
[http://dx.doi.org/10.1016/j.ejmech.2010.08.005] [PMID: 20813436]
[http://dx.doi.org/10.1021/jf60189a007] [PMID: 4733371]
[http://dx.doi.org/10.1080/14756360802318936] [PMID: 18642158]
[http://dx.doi.org/10.4103/0975-1483.90243]
[http://dx.doi.org/10.1155/2014/172791]
[http://dx.doi.org/10.1016/S0014-827X(02)01245-4] [PMID: 12164209]
[http://dx.doi.org/10.2478/v10007-009-0011-1] [PMID: 19564146]
[http://dx.doi.org/10.4103/0975-1483.93576] [PMID: 22523458]
[http://dx.doi.org/10.3329/icpj.v4i12.25597]
[PMID: 24250606]
[http://dx.doi.org/10.3797/scipharm.0803-10]
[PMID: 24250678]
[http://dx.doi.org/10.1016/j.jsps.2011.03.002] [PMID: 23960753]
[http://dx.doi.org/10.5530/ijper.51.2.31]
[http://dx.doi.org/10.1248/bpb.b14-00867] [PMID: 25947922]
[http://dx.doi.org/10.1016/j.bmcl.2016.02.043] [PMID: 26920799]
[PMID: 25425753]